VasocureĀ
The world's first drug to treat neointimal disease.Ā Vasocure is a clinical-stage nephrology therapeutics company with the world's first peptide to directly treat neointimal hyperplasia, or neointimal disease, arteriosclerosis, and atherosclerosis.
Behind the scenes
Video shoot and photography session at our New York City office.Ā
Ready to be understood?
Clarify complex offerings with consistent, scalable visual content that supports growth.
Book intro call
